Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$196M |
| 2 |
Verizon
VZ
|
+$166M |
| 3 |
Edison International
EIX
|
+$152M |
| 4 |
PPL
PPL Corp
PPL
|
+$122M |
| 5 |
Estee Lauder
EL
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ameren
AEE
|
+$140M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$136M |
| 3 |
ANDV
Andeavor
ANDV
|
+$111M |
| 4 |
LyondellBasell Industries
LYB
|
+$105M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 15.65% |
| 2 | Healthcare | 13.77% |
| 3 | Energy | 13.48% |
| 4 | Utilities | 8.99% |
| 5 | Financials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
WPP
WPP
$5.6B
| $1.06M | ﹤0.01% |
+10,283
| New | +$1.1M |
|
2177
HCI Group
HCI
$2.32B
| $1.06M | ﹤0.01% |
+29,035
| New | +$1.27M |
|
2178
John Wiley & Sons Class A
WLY
$2.74B
| $1.06M | ﹤0.01% |
+18,320
| New | +$1.02M |
|
2179
First Merchants
FRME
$2.62B
| $1.05M | ﹤0.01% |
+48,725
| New | +$1.03M |
|
|
IVC
2180
DELISTED
Invacare Corporation
IVC
| $1.05M | ﹤0.01% |
55,152
-24,176
| -30% | -$497K |
|
|
CELGZ
2181
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
| $1.05M | ﹤0.01% |
373,318
-66,828
| -15% | -$202K |
|
2182
Graham Holdings Company
GHC
$4.84B
| $1.05M | ﹤0.01% |
+2,464
| New | +$1.01M |
|
2183
CALL
Target
TGT
$75.4B
| $1.04M | ﹤0.01% |
17,200
-151,100
| -90% | -$8.96M |
|
2184
CALL
Nasdaq
NDAQ
$55.5B
| $1.04M | ﹤0.01% |
84,300
+82,500
| +4,583% | +$1.07M |
|
|
RSE
2185
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
| $1.04M | ﹤0.01% |
+60,209
| New | +$1.1M |
|
2186
Cabot Corp
CBT
$4.37B
| $1.04M | ﹤0.01% |
17,551
-26,072
| -60% | -$1.37M |
|
|
RGLS
2187
DELISTED
Regulus Therapeutics
RGLS
| $1.04M | ﹤0.01% |
958
-249
| -21% | -$276K |
|
|
ARO
2188
CALL
DELISTED
Aeropostale Inc
ARO
| $1.04M | ﹤0.01% |
206,500
-77,600
| -27% | -$540K |
|
|
RDS.A
2189
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.04M | ﹤0.01% |
15,186
+8,474
| +126% | +$566K |
|
|
AH
2190
DELISTED
Accretive Health
AH
| $1.03M | ﹤0.01% |
+129,000
| New | +$1.14M |
|
2191
Ducommun
DCO
$2.78B
| $1.03M | ﹤0.01% |
+41,122
| New | +$1.11M |
|
|
RBS.PRQ
2192
DELISTED
ROYAL BANK OF SCOTLAND GP PLC (THE) ADR REPSTG PFD SHS SER Q
RBS.PRQ
| $1.03M | ﹤0.01% |
43,676
-274,851
| -86% | -$6.39M |
|
2193
LSB Industries
LXU
$752M
| $1.03M | ﹤0.01% |
+35,715
| New | +$962K |
|
|
CDR
2194
DELISTED
Cedar Realty Trust, Inc
CDR
| $1.03M | ﹤0.01% |
25,486
+21,228
| +499% | +$879K |
|
2195
Daktronics
DAKT
$947M
| $1.02M | ﹤0.01% |
71,162
-157,298
| -69% | -$2.26M |
|
2196
ProShares UltraPro QQQ
TQQQ
$36.9B
| $1.02M | ﹤0.01% |
+799,248
| New | +$1.04M |
|
|
OME
2197
DELISTED
Omega Protein
OME
| $1.02M | ﹤0.01% |
84,697
-43,464
| -34% | -$498K |
|
|
LNW
2198
DELISTED
Light & Wonder
LNW
| $1.02M | ﹤0.01% |
74,334
+16,639
| +29% | +$242K |
|
|
SJI
2199
DELISTED
South Jersey Industries, Inc.
SJI
| $1.02M | ﹤0.01% |
36,284
-20,102
| -36% | -$552K |
|
2200
CALL
Royal Bank of Canada
RY
$284B
| $1.02M | ﹤0.01% |
+15,400
| New | +$996K |
|
Similar funds
Israel Englander's Q1 2014 Portfolio in Review
As of Q1 2014, Israel Englander held 4,356 positions worth $34.5B, up 8.9% from $31.7B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Israel Englander deployed $4.18B of net new capital in Q1 2014, opening 945 new positions and adding to 1,266 existing holdings. Its largest new stake was Bausch Health: 575,504 shares worth $75.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 16% of assets, down from 25% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Ameren, an estimated $140M trimmed.
- Israel Englander's largest Q1 2014 buy was Bausch Health: 575,504 shares worth $75.9M.
- Israel Englander added most to Devon Energy in Q1 2014, an estimated $196M increase.
- Israel Englander's biggest Q1 2014 reduction was Ameren, cutting an estimated $140M.
- Israel Englander fully exited PepsiCo in Q1 2014, selling an estimated $89.1M.
- Israel Englander's ten largest holdings make up 7.9% of its $34.5B portfolio in Q1 2014.
- Israel Englander opened 945 new positions and closed 958 in Q1 2014.
- Israel Englander's portfolio value rose 8.9% quarter-over-quarter to $34.5B.
Based on Millennium Management's 13F filing for Q1 2014, filed 15 May 2014.